Imagion Biosystems Overview

  • Founded
  • 1996
Founded
  • Status
  • Public
  • Employees
  • 6
Employees
  • Stock Symbol
  • IBX
Stock Symbol
  • Share Price
  • $0.03
  • (As of Friday Closing)

Imagion Biosystems General Information

Description

Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.

Contact Information

Formerly Known As
Senior Scientific
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Stock Exchange
ASX
Primary Office
  • 800 Bradbury South East
  • Suite 213
  • Albuquerque, NM 87106
  • United States
+1 (505) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Imagion Biosystems Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.03 $0.03 $0.03 - $0.10 $33.9M 1.12B 4.42M

Imagion Biosystems Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 42,454 52,096 101,661 7,181
Revenue 175 141 286
EBITDA (4,218) (3,415) (2,296)
Net Income (4,519) (3,689) (2,386)
Total Assets 10,232 10,856 3,411
Total Debt 33 508 614
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Imagion Biosystems Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Imagion Biosystems‘s full profile, request access.

Request a free trial

Imagion Biosystems Patents

Imagion Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200187822-A1 Detection, measurement, and imaging of cells using cellular internalization of nanoparticles Pending 15-Dec-2018 000000000
US-20170210773-A1 Synthesis of metal carboxylate compounds Abandoned 02-Jun-2014 0000000000 0
US-20160022196-A9 Nonsurgical determination of organ transplant condition Abandoned 16-Mar-2010 000000000
CA-2793209-A1 Nonsurgical determination of organ transplant condition Abandoned 16-Mar-2010 000000000
US-20120330133-A1 Nonsurgical determination of organ transplant condition Abandoned 16-Mar-2010 A61B5/413 0
To view Imagion Biosystems’s complete patent history, request access »

Imagion Biosystems Executive Team (2)

Name Title Board Seat Contact Info
Edward Flynn Founder and Chief Scientist
Brian Conn Chief Financial Officer
To view Imagion Biosystems’s complete executive team members history, request access »

Imagion Biosystems Board Members (1)

Name Representing Role Since
000000 000000 Imagion Biosystems Executive Chairman 000 0000
To view Imagion Biosystems’s complete board members history, request access »

Imagion Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial